Company intelligence / Profile preview

Nanite

Boston, Massachusetts, United Statesnanitebio.com ↗
Ownership
Private
Employees
~15
Development stage
Preclinical
01

Overview

Nanite is developing programmable, tissue-specific polymer nanoparticles for non-viral gene therapy. Their SAYER™ platform uses AI and high-throughput screening to engineer PNPs with improved safety and tissue targeting. The company has demonstrated strong preclinical results in animal models for efficient and specific genetic cargo delivery. Recent grants support development of DNA-based therapies for HIV using this technology; no clinical trial data reported yet.[4][5]

Therapeutic areas
PulmonologyInfectious Diseases
Modalities
Polymer nanoparticles (PNPs) for gene deliveryDNA/RNA-based therapeutics (via non-viral vectors)
Industry
Biotech
02

Drug pipeline

1 asset

Nanite HIV gene therapy

Preclinical
03

Partnerships

Bill & Melinda Gates Foundation (grant funding for HIV program)[3][4]Cystic Fibrosis Foundation (collaboration on lung-targeted gene therapy)[1]Academic collaboration with the Reineke Group at University of Minnesota[5]

Beyond the preview

Go deeper on Nanite.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call